Scleromyxedema, a therapeutic dilemma

Julio Cesar Salas-Alanis, Brayant Martinez-Jaramillo, Minerva Gomez-Flores, Jorge Ocampo-Candiani

Producción científicarevisión exhaustiva

11 Citas (Scopus)


Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.

Idioma originalEnglish
Páginas (desde-hasta)215
Número de páginas1
PublicaciónIndian Journal of Dermatology
EstadoPublished - 1 abr 2015

All Science Journal Classification (ASJC) codes

  • Dermatología


Profundice en los temas de investigación de 'Scleromyxedema, a therapeutic dilemma'. En conjunto forman una huella única.

Citar esto